Paris, July 22, 2026 – Jeantet advised Nexum Pharma on the acquisition of the assets of Livmed’s as part of the judicial liquidation proceedings before the Nice Commercial Court.

Nexum Pharma is a French healthtech company specializing in the home delivery of pharmacy and parapharmacy products. Through this acquisition, Nexum Pharma strengthens its technological capabilities and accelerates the development of its prescription medicine delivery service, with the ambition of offering a solution fully aligned with the applicable regulatory framework while supporting its expansion in France and internationally.

The transaction concerned the acquisition of Livmed’s technological assets, customer base and network of independent delivery partners.

The Jeantet team comprised Guillaume Fornier (Partner, M&A), Chiara Seguin-Hassan (Associate, M&A).

Download the press release